Moritz Hahn
Impact in
- Accounting top 5%
- Corporate Finance and Governance
- Private Equity and Venture Capital
- Chemical Health and Safety top 5%
Papers in
-
- Retinal Diseases and Treatments 5
-
- Adipokines, Inflammation, and Metabolic Diseases 3
- Co-authors
- Oliver Gottschalg (2 shared papers)Viral V. Acharya (2 shared papers)F. Oberhäuser (5 shared papers)Matthias Laudes (5 shared papers)Wilhelm Krone (4 shared papers)Olaf Schultz (1 shared paper)Andrea Rubbert‐Roth (1 shared paper)Sascha Fauser (7 shared papers)
- Journals
- Hormone and Metabolic Research (3 papers)Investigative Ophthalmology & Visual Science (3 papers)PLoS ONE (3 papers)Palliative & Supportive Care (2 papers)Otology & Neurotology (2 papers)
- Partner nations
- GermanyNetherlandsUnited States
In The Last Decade
Moritz Hahn
40 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 120
- Accounting 353
- Chemical Health and Safety 20
- Occupational Therapy 104
- Ophthalmology 125
- Finance 98
Countries citing papers authored by Moritz Hahn
This map shows the geographic impact of Moritz Hahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moritz Hahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moritz Hahn more than expected).
Fields of papers citing papers by Moritz Hahn
This network shows the impact of papers produced by Moritz Hahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moritz Hahn. The network helps show where Moritz Hahn may publish in the future.
Co-authors
The 25 scholars most cited alongside Moritz Hahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 243 | |
| 2 | 2010 | 183 | |
| 3 | 2010 | 128 | |
| 4 | 2012 | 88 | |
| 5 | 2009 | 82 | |
| 6 | 2012 | 64 | |
| 7 | 2017 | 62 | |
| 8 | 2011 | 57 | |
| 9 | 2014 | 57 | |
| 10 | 2014 | 48 | |
| 11 | 2010 | 46 | |
| 12 | 2007 | 43 | |
| 13 | 2011 | 41 | |
| 14 | 2014 | 38 | |
| 15 | 2000 | 36 | |
| 16 | 2013 | 35 | |
| 17 | 2014 | 31 | |
| 18 | 2013 | 28 | |
| 19 | 2011 | 27 | |
| 20 | 2014 | 26 |
About Moritz Hahn
Moritz Hahn is a scholar working on Ophthalmology, Epidemiology, Surgery, Pediatrics, Perinatology and Child Health and Cognitive Neuroscience, having authored 40 papers that have together received 1.7k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (5 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Hearing Loss and Rehabilitation (3 papers), Capital Investment and Risk Analysis (2 papers), Private Equity and Venture Capital (2 papers), Safe Handling of Antineoplastic Drugs (2 papers), Corporate Finance and Governance (2 papers) and Salivary Gland Tumors Diagnosis and Treatment (2 papers). The work is most often cited by research in Accounting (353 citations), Chemical Health and Safety (20 citations), Occupational Therapy (104 citations), Ophthalmology (125 citations) and Finance (98 citations). Moritz Hahn has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Oliver Gottschalg, Viral V. Acharya, F. Oberhäuser, Matthias Laudes, Wilhelm Krone, Olaf Schultz, Andrea Rubbert‐Roth, Sascha Fauser, Bernd Kirchhof and Anneke I. den Hollander. Their work appears in journals such as Hormone and Metabolic Research, Investigative Ophthalmology & Visual Science, PLoS ONE, Palliative & Supportive Care and Otology & Neurotology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.